Discover
Go To Health!
Go To Health!
Author: Jonathan Marx, MBA
Subscribed: 4Played: 16Subscribe
Share
© 2025 Jonathan Marx, MBA
Description
Go To Health Media features health experts from around the world who bring evidence-based education from Western, alternative, and holistic practices. It is supported by our website and social media properties. We bring together the public (seeking relevant, reputable, and proven solutions to their healthcare needs) and healthcare providers and companies, trying to reach target audiences with quality information, services, and products. Follow-up connections with our experts are highlighted, so that we help our audiences achieve optimal health via reputable, up-to-date health information, services and products. Join us on our GoToHealth Podcast and our website at https://gotohealthmedia.com/video.
281 Episodes
Reverse
Slightly blurry vision or a few floaters might seem harmless, but for people with diabetes, it could be a sign that sight-threatening damage is already happening behind the scenes. In this episode of Go to Health, Jonathan Marks speaks with Dr. Gaurav K. Shah, President of the American Society of Retina Specialists, about diabetic retinopathy (diabetic eye disease) and how to prevent blindness.
Dr. Shah explains how diabetes damages the blood vessels in the retina—the "film" of the eye—often with zero early warning signs. He breaks down why an annual dilated eye exam is non-negotiable for anyone with diabetes, what modern treatments look like today, and the truth behind recent media reports linking GLP-1 drugs like Ozempic and Wegovy to sudden vision loss.
Key Insights:
- Diabetic retinopathy is caused by abnormal blood vessel growth and swelling in the retina, and symptoms can include blurry vision, floaters, shadows, or a "snow globe" effect.
- Retinal changes typically begin 5 to 6 years after a diabetes diagnosis, though many patients live with undiagnosed diabetes for years beforehand.
- A standard glasses exam is not enough; people with diabetes need an annual dilated eye exam—ideally with a retina specialist—using imaging like OCT scans.
- Modern treatments for diabetic eye disease include eye injections, laser therapy, and surgery to remove blood and scar tissue, making early detection critical.
- Managing A1C, blood pressure, cholesterol, and kidney health directly protects your eyes.
- While there have been media reports of optic neuropathy in patients taking GLP-1 medications, there is currently no conclusive evidence of a causal link; however, anyone with diabetes experiencing vision changes should see a retina specialist immediately.
⏱️ Chapters:
00:00 Intro & The Hidden Risk of Diabetic Eye Disease
00:52 What is Diabetic Retinopathy?
01:34 Warning Signs You Should Never Ignore
02:14 How Common is Diabetic Eye Disease?
02:50 Dilated Eye Exams & How Often You Need Them
04:03 Optometrist vs. Retina Specialist
05:06 Modern Treatments for Diabetic Retinopathy
05:48 Controlling A1C, Blood Pressure & Cholesterol
06:30 Do GLP-1 Drugs Cause Sudden Vision Loss?
07:16 Final Advice on Preventing Blindness
If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening!
🔗 Resources & Links Mentioned:
- American Society of Retina Specialists (ASRS): https://tinyurl.com/ASRS-org
- See for a Lifetime: https://tinyurl.com/See-for-a-lifetime
- Go to Health Media: https://tinyurl.com/Go-to-Health-Media
Learn more about your ad choices. Visit megaphone.fm/adchoices
Over 292,000 people search for answers about diabetes every month, and veterans often face unique risks and challenges managing the disease. In this special Veteran's Day episode of Go to Health, Jonathan Marx sits down with Grammy-nominated musicians Michael and Tanya Trotter (The War and Treaty), alongside board-certified endocrinologist Dr. Craig William, to discuss Type 2 diabetes management, mental health, and the healing power of support.
Army veteran Michael Trotter shares his journey from ignoring severe symptoms like blurry vision and frequent urination to landing in the ER on his birthday. With the steadfast support of his wife Tanya, Michael transformed his health by adopting a Mediterranean diet, incorporating daily exercise, and utilizing Ozempic to hit his A1C targets.
Key Insights:
- Type 2 diabetes warning signs include extreme thirst, frequent urination, and blurry vision; severe untreated cases can also lead to unexplained weight loss.
- The disease disproportionately affects minority communities, with a 12% incidence rate in the Black community compared to 7% in the Caucasian community.
- Dr. William explains that Ozempic (semaglutide) is FDA-approved not only to lower A1C in diabetes patients, but also to decrease cardiovascular death risks and slow the decline of kidney function.
- Michael bravely discusses his battle with moral injury after serving in the military, explaining how he initially turned to comfort foods to cope before finding a healthier, purposeful path.
⏱️ Chapters:
00:00 Intro & Honoring Veteran's Day
01:12 Michael Trotter's Type 2 Diabetes Diagnosis
03:01 Adopting a Mediterranean Diet
05:05 Tanya's Role: Empathy and Family Support
06:31 Common Symptoms & High-Risk Demographics
07:29 Dr. William Explains Ozempic & FDA Approvals
09:13 Coping with PTSD, Food, and Mental Health
10:47 The Story Behind "The War and Treaty"
13:13 Final Advice on Hope and Taking Action
If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening!
🔗 Resources & Links Mentioned:
- The War and Treaty: https://www.thewarandtreaty.com/
- Ozempic Information: https://www.ozempic.com/
- Go to Health Media: https://gotohealthmedia.com/ozempic-does-more-than-lower-a1c-heres-what-veterans-need-to-know/
Learn more about your ad choices. Visit megaphone.fm/adchoices
No Surgery, No Chemo or Radiation for Colorectal Cancer? How one young patient avoided major surgery and an oncologist explains a new immunotherapy approach.
Rectal cancer patient Dan Santonocito shares how he avoided surgery, chemotherapy and radiation after treatment with Jemperli (dostarlimab). He is joined by board-certified medical oncologist Meredith Pelster, MD, of SCRI Oncology Partners in Nashville, who specializes in gastrointestinal cancers as well as head and neck cancers, to explain how cancer immunotherapy is changing colorectal cancer care, who may be eligible, and what patients should ask their own oncology team.
In this interview: Dan's rectal cancer diagnosis story as a young adult, why standard treatment often means surgery plus chemo and radiation, how Jemperli works as an immunotherapy, what complete response means, side effects and monitoring, and what this case means for the future of colon cancer and colorectal cancer treatment.
This video is for education only and is not medical advice. Talk to your own doctor about cancer treatment options.
Guests:
Dan Santonocito - rectal cancer patient and Jemperli story
Meredith Pelster, MD - Board-certified medical oncologist, SCRI Oncology Partners, Nashville - gastrointestinal and head and neck cancers
About GoToHealth! - Evidence-based health interviews with experts from around the world on fitness, mental health, cancer, and wellness. More at https://gotohealthmedia.com/no-surgery-no-chemo-for-colon-cancer-how-cancer-immunotherapy-changed-everything/.
Chapters:
00:00 Intro & Dan's Initial Symptoms
03:26 The Rising Rate of Rectal Cancer in Young Adults
05:49 Advocating for Alternatives: Finding Jemperli
08:09 Why Every Patient Needs Biomarker Testing (dMMR/MSI)
10:48 When Should You Get a Colonoscopy?
11:42 Dan's Cancer-Free Life Today
13:23 Standard Treatment vs. Immunotherapy
14:23 Final Advice on Patient Self-Advocacy
If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening!
Learn more about your ad choices. Visit megaphone.fm/adchoices
For years, Sandra Miller's severe leg numbness and pain were dismissed by doctors as just "stress". In this powerful episode of Go to Health, Jonathan Marx sits down with Sandra and UCLA sarcoma specialist Dr. Noah Federman to discuss the rare condition that was actually causing her debilitating symptoms: a desmoid tumor.
Key Insights:
- Sandra spent four years fighting for a proper diagnosis after her symptoms—which began as tingling after a severe pelvic fracture—worsened into pain that prevented her from sleeping, walking, or driving.
- Desmoid tumors are rare connective tissue growths (affecting only 1,000 to 1,500 people a year in the US) that primarily occur in young adults between the ages of 20 and 45.
- Because of their extreme rarity, these tumors are incredibly difficult to diagnose and are frequently mistaken for common musculoskeletal issues, sprains, or even anxiety.
- Treatment has drastically evolved over the last two decades; while surgery used to be the standard approach (often resulting in the tumor returning), the FDA recently approved Ogsiveo (nirogacestat), the first and only medication specifically designed to halt or slow the progression of these tumors.
- Both guests stress that you are your own best advocate—if your symptoms persist without relief, demand further imaging, biopsies, or a referral to a multidisciplinary sarcoma center.
⏱️ Chapters:
00:00 Intro & Sandra's 4-Year Diagnostic Journey
03:49 What is a Sarcoma and a Desmoid Tumor?
04:51 Why Rare Tumors are So Hard to Diagnose
06:31 Ogsiveo: The New FDA-Approved Treatment Option
07:45 Demographics: Who Gets Desmoid Tumors?
08:21 Sandra's Life Today on Medication
09:35 The Crucial Importance of Patient Self-Advocacy
If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening!
Learn more here: https://gotohealthmedia.com/leg-pain-at-28-led-to-a-rare-cancer-diagnosis/
Learn more about your ad choices. Visit megaphone.fm/adchoices
Ovarian cancer symptoms are often dismissed as normal daily discomforts until the disease has already advanced. In this inspiring episode of Go to Health, Jonathan Marx sits down with Flower Miller, who was diagnosed with metastatic stage 4 ovarian cancer at just 41 years old.
Key Insights:
- Early symptoms of ovarian cancer can include fatigue, frequent urination, feeling full after only a few bites, and a hard, bloated belly.
- Flower's cancer was discovered via a transvaginal ultrasound and CT scan after her primary care doctor pressed on her stomach and she noticed pain.
- She attributes her survival to an aggressive treatment plan, enrolling in a two-year clinical trial for maintenance therapy, and building a collaborative relationship with a specialized gynecological oncologist.
- Discovering she carried the BRCA1 gene mutation led Flour to undergo a prophylactic double mastectomy to prevent future breast cancer.
⏱️ Chapters:
00:00 Intro & Flour Miller's Story
01:05 Easily Missed Ovarian Cancer Symptoms
02:20 Almost Misdiagnosed with IBS
04:01 Processing a Stage 4 Cancer Diagnosis
05:40 Dose-Dense Chemotherapy & Surgeries
07:03 Self-Advocacy & Clinical Trials
09:40 The BRCA1 Gene & Family History
11:07 GSK's Our Way Forward Program
12:30 Tangible Hope for the Newly Diagnosed
Learn more here:
https://gotohealthmedia.com/ovarian-cancer-symptoms-women-ignore-until-its-too-late/
If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening!
Learn more about your ad choices. Visit megaphone.fm/adchoices



